iMetabolic Biopharma
About this raise
IMetabolic Biopharma, with a valuation of $25 million, is raising funds on StartEngine. It is an early-stage drug discovery company developing new, life-saving drugs to fight against some of today's most devastating chronic diseases. IMetabolic Biopharma technology-powered iPlatform™ pipeline removes the roadblocks that typically make drug development slow, expensive, and inefficient. Currently the company is pre-market. Urban Austin Kiernan founded the company in 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,230,000. The campaign proceeds will be used for Therapeutic asset research and development, software research and development, executive compensation and working capital.
Investment Overview
Invested : $365,915
Deal Terms
Total Commitments
- Platform
- StartEngine
- Start Date
- 12/19/2022
- Close Date
- 07/06/2023
$10,000
$1,230,000
$250
Convertible Note
Growth Stage
RegCF
$25,000,000
10%
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Financials
-
Revenue
-
$0
as of FY2022
- Monthly Burn
-
$7,876
as of FY2022
-
Runway
-
0.6 months
as of FY2022
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $15,150,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 07/06/2023 | StartEngine | $25,000,000 | $365,915 | Convertible Note | Funded | RegCF |